Varespladib trial terminated, increased MI risk

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1484卷 / 1期

关键词：

D O I：

10.1007/s40278-014-8217-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1 / 1

相关论文

共 50 条

[1] HRT trial terminated early due to increased breast cancer risk
Reactions Weekly, 2004, 988 (1) : 3 - 3
[2] No increased risk of MI with protease inhibitors
Reactions Weekly, 2000, 789 (1) : 3 - 3
[3] Increased risk of MI with tricyclics, but not SSRIs?
Reactions Weekly, 2000, 788 (1) : 6 - 6
[4] PIs associated with increased risk of MI
Reactions Weekly, 2002, 931 (1) : 5 - 5
[5] Calcium antagonists not associated with increased risk of MI
Reactions Weekly, 1997, 643 (1) : 5 - 5
[6] Testosterone products: increased risk of stroke and MI?
Reactions Weekly, 2015, 1543 (1) : 6 - 6
[7] Sildenafil: no increased risk of death due to MI
Reactions Weekly, 2002, 909 (1) : 4 - 4
[8] HRT and prothrombin variant: increased risk of MI?
Reactions Weekly, 2001, 841 (1) : 6 - 6
[9] SSRIs and TCAs not associated with increased risk of MI?
Reactions Weekly, 2005, 1050 (1) : 4 - 4
[10] Calcium supplements associated with increased MI risk
Reactions Weekly, 2012, 1406 (1) : 4 - 4

← 1 2 3 4 5 →